Associate Professor Serigne Lo
A/Prof Serigne Lo leads a team responsible for the design & analysis of clinical trials, and the development of tools that guide the treatment of melanoma patients. Let's dive into his life and research!
Bondi Rescue star shares skin cancer risk as a warning to others
Australians are being urged to take sun safety seriously as the weather warms up, with Bondi Rescue star Tommy Woodriff sharing his skin cancer risk as a warning to others.
Dr Jordan Conway
Meet Dr Jordan Conway, whose crucial research focuses on melanoma metastases in the liver, neoadjuvant immunotherapy and strategies to overcome treatment resistance.
Fundraising to help save lives from melanoma
From a gourmet dinner to pub meat raffles, a 1000km walk to a marathon, and a golf day afternoon tea, read more about the inspiring stories behind our Community Fundraisers. Find out how you can fundraise to support melanoma research.
Eva Shteinman
Eva Shteinman is a PhD student in the MIA research team. In our latest Q&A session, we asked Eva everything from how she became a melanoma researcher, to her hidden talents, and more!
Désirée Sexauer
Désirée Sexauer is a PhD student at Edith Cowan University in WA, and is a recipient of a MIA Postgraduate Research Scholarship. Read her Q&A.
Dr Camelia Quek
Dr Camelia Quek is a Postdoctoral Researcher at Melanoma Institute Australia. Camelia answers our questions about her research and personal insights.
A month of inspiring Community Fundraising
Read more about the inspiring stories behind our Community Fundraisers. Find out how you can fundraise to support melanoma research, which is also impacting other cancers.
Our photo tribute to Kay Van Norton Poche AO
Pictures tell a thousand words, and we are proud to share this photo tribute of Kay and her friendship with us over many years.
Vale Kay Van Norton Poche AO
It is with a heavy heart that we notify you that Kay Van Norton Poche AO, one of Melanoma Institute Australia's great friends and committed supporters, passed away on 14 June 2024, following a long illness.